Triple Antiviral Combo May Speed COVID-19 Recovery Triple Antiviral Combo May Speed COVID-19 Recovery

The combination of interferon-beta1, lopinavir/ritonavir, and ribavirin shortened median time to COVID-19 viral negativity by 5 days, according to results of an open-label, randomized phase 2 trial.Medscape Medical News
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news